Rui Ni
Daping, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Comparison of rat hypertrophic scar models: Caudal tension model with superior pathological consistency.
Journal: Animal models and experimental medicine
Published: January 11, 2026
A Multifunctional Hydrogel Incorporating Luteolin-Encapsulated ROS-Responsive Nanoparticles and Stem Cells Promotes Bacterial-Infected Wound Healing.
Journal: Pharmaceutics
Published: October 21, 2025
Integrating UPLC-Q-TOF-MS, network pharmacology, molecular docking, and molecular dynamics simulation to reveal the material basis and mechanism of Xiangshao sanjie oral liquid in treating hyperplasia of mammary glands.
Journal: Journal of pharmaceutical and biomedical analysis
Published: February 24, 2025
Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment.
Journal: Bioengineering (Basel, Switzerland)
Published: December 02, 2024
Integrating metabolomics and network pharmacology to explore the mechanism of Xiangshao Sanjie Oral Liquid in treating rats with mammary gland hyperplasia.
Journal: Journal of ethnopharmacology
Published: December 02, 2024
Khdrbs1 drives re-differentiation of bipotential progenitor cells by inhibiting p53 in zebrafish biliary-mediated liver regeneration.
Journal: Development (Cambridge, England)
Published: July 21, 2024
Terminalia bellirica (Gaertn.) Roxb. Extracts reshape the perifollicular microenvironment and regulate the MAPK pathway for androgenetic alopecia treatment.
Journal: Journal of ethnopharmacology
Published: June 05, 2024
Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress.
Journal: Frontiers in pharmacology
Published: February 05, 2024
Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study.
Journal: Frontiers in pharmacology
Published: November 24, 2023
Disproportionality Analysis of Nusinersen in the Food and Drug Administration Adverse Event Reporting System: A Real-World Postmarketing Pharmacovigilance Assessment.
Journal: Pediatric neurology
Published: October 09, 2023
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.
Journal: Therapeutic advances in drug safety
Published: July 07, 2023
Cost-effectiveness of serplulimab as first-line therapy for extensive-stage small cell lung cancer in China.
Journal: Frontiers in immunology
Published: May 18, 2023
Last Updated: 09/26/2026